167 related articles for article (PubMed ID: 16690090)
21. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
22. [D2-subtype of dopaminergic receptors is involved in anxiety behavior in ovariectomized rats].
Fedotova IuO
Patol Fiziol Eksp Ter; 2008; (3):10-3. PubMed ID: 18942469
[TBL] [Abstract][Full Text] [Related]
23. Behavioral effects of dehydroepiandrosterone in adult male rats.
Fedotova J; Sapronov N
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1023-7. PubMed ID: 15380863
[TBL] [Abstract][Full Text] [Related]
24. Manipulation of D2 receptors with quinpirole and sulpiride affects locomotor activity before spatial behavior of rats in an active place avoidance task.
Stuchlik A; Rehakova L; Rambousek L; Svoboda J; Vales K
Neurosci Res; 2007 Jun; 58(2):133-9. PubMed ID: 17360063
[TBL] [Abstract][Full Text] [Related]
25. Examination of the influence of 3,5-DHPG on behavioral activity of angiotensin II.
Hoły Z; Wiśniewski K
Pol J Pharmacol; 2001; 53(3):235-43. PubMed ID: 11785924
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV.
Tchekalarova J; Sotiriou E; Angelatou F
Brain Res; 2004 Oct; 1024(1-2):159-66. PubMed ID: 15451378
[TBL] [Abstract][Full Text] [Related]
27. S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
Millan MJ; Loiseau F; Dekeyne A; Gobert A; Flik G; Cremers TI; Rivet JM; Sicard D; Billiras R; Brocco M
J Pharmacol Exp Ther; 2008 Mar; 324(3):1212-26. PubMed ID: 18096759
[TBL] [Abstract][Full Text] [Related]
28. 2R,4R-APDC influence on hypoxia-induced impairment of learning and memory processes in passive avoidance test.
Car H; Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 2004; 56(5):527-37. PubMed ID: 15591640
[TBL] [Abstract][Full Text] [Related]
29. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
[TBL] [Abstract][Full Text] [Related]
30. Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia.
Bruno Rde B; Marques TF; Batista TM; Lima JC; de Arruda KG; Lima PF; Santos Nda S; Cunha GM; Vitor HV; Viana GS
Brain Res; 2009 Mar; 1260():55-64. PubMed ID: 19161991
[TBL] [Abstract][Full Text] [Related]
31. Effect of "enriched environment" during development on adult rat behavior and response to the dopamine receptor agonist apomorphine.
Hoffmann LC; Schütte SR; Koch M; Schwabe K
Neuroscience; 2009 Feb; 158(4):1589-98. PubMed ID: 19110038
[TBL] [Abstract][Full Text] [Related]
32. Trandolapril attenuates acquisition of conditioned avoidance in rats.
Braszko JJ; Pasławski L; Karwowska-Polecka W; Hołownia A
Pol J Pharmacol; 2000; 52(3):195-201. PubMed ID: 11055576
[TBL] [Abstract][Full Text] [Related]
33. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.
Camarasa J; Marimón JM; Rodrigo T; Escubedo E; Pubill D
Eur J Pharmacol; 2008 Jul; 589(1-3):132-9. PubMed ID: 18582864
[TBL] [Abstract][Full Text] [Related]
34. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Westlind-Danielsson A; Gustafsson K; Andersson I
Eur J Pharmacol; 1994 Dec; 288(1):89-95. PubMed ID: 7705472
[TBL] [Abstract][Full Text] [Related]
35. Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.
Vorhees CV; Johnson HL; Burns LN; Williams MT
Neurotoxicol Teratol; 2009; 31(1):1-10. PubMed ID: 18930132
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin IV and LVV-haemorphin 7 enhance spatial working memory in rats: effects on hippocampal glucose levels and blood flow.
De Bundel D; Smolders I; Yang R; Albiston AL; Michotte Y; Chai SY
Neurobiol Learn Mem; 2009 Jul; 92(1):19-26. PubMed ID: 19233301
[TBL] [Abstract][Full Text] [Related]
37. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain.
Giménez-Llort L; Schiffmann SN; Shmidt T; Canela L; Camón L; Wassholm M; Canals M; Terasmaa A; Fernández-Teruel A; Tobeña A; Popova E; Ferré S; Agnati L; Ciruela F; Martínez E; Scheel-Kruger J; Lluis C; Franco R; Fuxe K; Bader M
Neurobiol Learn Mem; 2007 Jan; 87(1):42-56. PubMed ID: 16824773
[TBL] [Abstract][Full Text] [Related]
38. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.
Schreiber R; Vivian J; Hedley L; Szczepanski K; Secchi RL; Zuzow M; van Laarhoven S; Moreau JL; Martin JR; Sik A; Blokland A
Eur Neuropsychopharmacol; 2007 Mar; 17(4):277-88. PubMed ID: 16989988
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic mechanisms controlling urethral function in rats.
Ogawa T; Seki S; Masuda H; Igawa Y; Nishizawa O; Kuno S; Chancellor MB; de Groat WC; Yoshimura N
Neurourol Urodyn; 2006; 25(5):480-9. PubMed ID: 16721842
[TBL] [Abstract][Full Text] [Related]
40. Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats.
Shah AA; Sjovold T; Treit D
Eur J Neurosci; 2004 Jun; 19(12):3393-7. PubMed ID: 15217397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]